The latest price target for Precigen (NASDAQ:PGEN) was reported by HC Wainwright & Co. on November 15, 2024. The analyst firm set a price target for $4.00 expecting PGEN to rise to within 12 months (a possible 378.07% upside). 12 analyst firms have reported ratings in the last year.

The latest analyst rating for Precigen (NASDAQ:PGEN) was provided by HC Wainwright & Co., and Precigen reiterated their buy rating.

There is no last upgrade for Precigen

The last downgrade for Precigen Inc happened on March 22, 2024 when JP Morgan changed their price target from N/A to N/A for Precigen Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Precigen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Precigen was filed on November 15, 2024 so you should expect the next rating to be made available sometime around November 15, 2025.

While ratings are subjective and will change, the latest Precigen (PGEN) rating was a reiterated with a price target of $4.00 to $4.00. The current price Precigen (PGEN) is trading at is $0.84, which is out of the analyst’s predicted range.